[27PO10-am2] Pharmacotherapies (Cancer)-1

[27PO10-am2-08S] A novel acetogenin analog, NK-134 inhibits human lung cancer A549 cell proliferation and suppresses A549 xenograft growth

○Kounosuke Konishi¹, Seiko Okamoto¹, Naoto Kojima², Kio Egawa¹, Shota Ando¹, Chiami Moyama¹, Hiromi Ii¹, Susumu Nakata¹ (1. Dept. of Clinical Oncology, Kyoto Pharmaceutical University, 2. Dept. of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University)